ConductScience.org, home

Cell line · CVCL_1844

OCI-AML-3

Cancer cell line, Homo sapiens. Adult acute myelomonocytic leukemia. 84 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. OCI-AML-3. Cell lines, record CVCL_1844. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1844

On this page

Cell line

As Cellosaurus gives it.

Name
OCI-AML-3
Accession
CVCL_1844
RRID
RRID:CVCL_1844
Synonyms
OCI-Aml-3, OCI/AML-3, OCI-AML3, OCI/AML3, OCI AML3, OCIAML3, Ontario Cancer Institute-Acute Myeloid Leukemia-3
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
57Y
Category
Cancer cell line
Diseases
Adult acute myelomonocytic leukemia (NCIt C7962); Acute myelomonocytic leukemia (ORDO Orphanet_517)
Derived from
Peripheral blood (in situ)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers84

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia.Sci Adv2026Its Methods give the RRID and name the linePubMed
Extracellular vesicle-delivered siRNA targeting RCN1 suppresses acute myeloid leukemia through TFAM-dependent mtDNA-cGAS-STING signaling.Extracell Vesicles Circ Nucl Acids2026Its Methods give the RRID and name the linePubMed
Functional-genomic prioritization identifies MED12 as a candidate RNAi vulnerability in acute myeloid leukemia: evaluation of a T22 peptide-functionalized LNP-siRNA formulation.Front Pharmacol2026Its Methods give the RRID and name the linePubMed
Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism.EMBO Rep2026Its Methods give the RRID and name the linePubMed
Novel noscapine derivative induces AML differentiation by dual-engaging DHODH and mitochondrial lipids to trigger a metabolic-epigenetic-transcriptional cascade.Acta Pharm Sin B2026Its Methods give the RRID and name the linePubMed
A structure-based modeling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.iScience2026Its Methods give the RRID and name the linePubMed
Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.Leukemia2026Its Methods give the RRID and name the linePubMed
Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia.Nat Commun2026Its Methods give the RRID and name the linePubMed
LDLRAD2 drives glycolysis and angiogenesis to promote extramedullary infiltration in acute myeloid leukemia.iScience2026Its Methods give the RRID and name the linePubMed
Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy.Cancer Res2026Its Methods give the RRID and name the linePubMed

1 to 10 of 84

See all 84 papers

Relatives7

RelationCell lineAccessionProblemSource
Derived from itEDITGENE ASXL1 Knockout OCI-AML3 Cell LineCVCL_F5INCell lines
Derived from itEDITGENE OCI-Aml-3-CopGFPCVCL_F6CICell lines
Derived from itEDITGENE OCI-Aml-3-FLUCCVCL_F5V1Cell lines
Derived from itHyCyte OCI-AML3 KO-hFGL2CVCL_D6C9Cell lines
Derived from itOCI-AML3/HaABCG2 clone 3.3CVCL_D6NGCell lines
Derived from itOCI-AML3/HaABCG2 clone 6.2CVCL_5227Cell lines
Derived from itOCI-AML3DNRCVCL_D6NFCell lines

Cell banks5

Cell bankCatalog numberStatusSource
CCTCCGDC0216Cellosaurus
DSMZACC-582DSMZ
EDITGENEEDC00313EDITGENE
HysigenTCH-C384Hysigen
UbigeneYC-C022Ubigene

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1844

GET https://conductscience.org/api/cell-lines/v1/CVCL_1844/papers?page=2